Second, the use of a monkey model of type-1 diabetes provided translational evidence that the necroptosis signaling RIPK3 and MLKL are activated in diabetic hearts and may represent new therapeutic targets for cardiac complications of diabetes. This evidence concerns the gene MLKL and diabetes mellitus.